腹腔镜胆囊切除联合腹腔镜辅助经胃对接ERCP在胃旁路术患者中的应用
基于瑞典GallRiks注册数据,比较胃旁路术(RYGB)患者行腹腔镜胆囊切除(LC)联合腹腔镜辅助经胃对接ERCP(LAERCP)与非RYGB患者行LC联合对接ERCP的结局。RYGB组治疗成功率100%高于非RYGB组91.4%(p=0.018),围术期不良事件8.8% vs 2.3%(p<0.001)但RYGB组无术后后果,手术时间及住院时间更长。结论认为该联合术式安全有效。
要点
- RYGB患者LC联合LAERCP治疗成功率100%,高于非RYGB组的91.4%。
- RYGB组围术期不良事件8.8%高于非RYGB组2.3%,但无术后后果。
- RYGB组手术时间180 vs 131分钟、住院2 vs 1天均更长。
核心结论
- LC同期行对接LAERCP是RYGB术后胆总管结石安全有效的处理方法。
- 尽管围术期事件率较高,结局相对既往非同期LAERCP数据仍良好。
- 研究支持该对接技术作为瑞典RYGB患者的标准治疗,并为国际指南提供注册证据。
研究设计与样本
- 回顾性研究,基于瑞典GallRiks注册2016年9月至2021年6月前瞻性收集的全国队列数据。
- 纳入所有行LC联合同日对接ERCP的患者,比较既往RYGB组与无上腹部手术史的非RYGB组。
主要发现
- 治疗成功率RYGB组100%(60例) vs 非RYGB组91.4%(3067例),p=0.018。
- 围术期不良事件RYGB组8.8% vs 非RYGB组2.3%,p<0.001,但RYGB组无术后后果。
- 术后不良事件、抗生素使用及再入院率两组相似。
- 中位手术时间RYGB组180分钟 vs 非RYGB组131分钟,p<0.001。
- 中位住院时间RYGB组2天 vs 非RYGB组1天,p<0.001;两组均无死亡。
临床怎么用
- 对RYGB术后合并胆总管结石患者,可考虑LC同期行对接LAERCP。
- 应预期围术期不良事件率较高、手术时间及住院时间更长,但无术后后果。
局限性
- 回顾性注册研究设计,可能存在选择偏倚和未测量混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopy-assisted transgastric rendezvous ERCP (LAERCP) is a perioperative treatment option for common bile duct stones (CBDS) in Roux-en-Y gastric bypass (RYGB) patients. Although rendezvous ERCP (RV-ERCP) is a safe treatment for CBDS, comparative data with LAERCP in larger cohorts are lacking. This study compares outcomes of laparoscopic cholecystectomy (LC) and LAERCP in RYGB patients with LC and rendezvous ERCP (RV-ERCP) in patients with unaltered anatomy, using an extensive validated national registry. METHODS: A retrospective study on prospectively collected nationwide cohort data from the Swedish Registry of Gallstone Surgery and ERCP (GallRiks), including all patients from September 2016 to June 2021 who underwent LC with same-day rendezvous ERCP. Patients with prior RYGB (RYGB group) were compared to those without previous upper abdominal surgery (non-RYGB group). Outcome measures was therapeutic success, peri- and postoperative adverse events, procedural time and readmissions. RESULTS: Seventy RYGB and 4342 non-RYGB patients were identified. CBDS were detected in 60 and 3067 patients, respectively. Therapeutic success was 100% in the RYGB group versus 91.4% in the non-RYGB group (p = 0.018). Perioperative adverse events occurred in 8.8% and 2.3% of cases (p < 0.001), but none in the RYGB group had postoperative consequences. Postoperative adverse events, antibiotic use and readmissions were similar. Median procedural time (180 vs. 131 min, p < 0.001) and hospital stay (2 vs. 1 days, p < 0.001) were longer for the RYGB group. No mortality occurred in either group. CONCLUSIONS: Concomitant rendezvous LAERCP during LC is a safe and effective method for managing CBDS after RYGB. Despite a higher rate of perioperative events, outcomes were favorable relative to previously published data for non-concomitant LAERCP. These findings support LAERCP with rendezvous technique as the standard of care for RYGB patients in Sweden and provide registry-based evidence to inform future international guidelines.
引用
- Liljegard S, Larsson PA, Haraldsson E, et al. Laparoscopic cholecystectomy with laparoscopy-assisted transgastric rendezvous ERCP in gastric bypass patients. Surg Endosc. 2026. PMID: 41820590. doi:10.1007/s00464-026-12704-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。